Galapagos NV (NASDAQ:GLPG)

185.07
Delayed Data
As of Nov 20
 +0.72 / +0.39%
Today’s Change
85.00
Today|||52-Week Range
192.89
+101.73%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$11.4B

Company Description

Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. It operates through the Research and Development and Fee-for-Services segment. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.

Contact Information

Galapagos NV
Industriepark Mechelen Noord
Mechelen Brussels Region 2800
P:(321) 534-2900
Investor Relations:
(781) 460-1784

Employees

Shareholders

Mutual fund holders7.10%
Other institutional6.74%
Individual stakeholders--

Top Executives

There are no executives to display.